RSV immunisations will be available to newborns and babies aged up to six months old and the programme will run over the winter, the Minister for Health has said.

CHILDREN UP TO six months old will be provided with an Respiratory Syncytial Virus (RSV) vaccine as part of an expanded ...

While most cases are mild, it can lead to bronchiolitis and pneumonia in babies and usually hundreds are hospitalised every year.

With the approach of fall likely bringing the usual uptick in respiratory illness, the provincial government is boosting its ...

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

The presence of more comorbidities was linked to longer hospital stays and worse clinical outcomes among patients with RSV-, influenza-, and hMPV-related pneumonia.

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It said that the jab ...

The New York State Department of Health has updated a standing order, allowing pharmacists to administer the respiratory ...

The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory Committee on Immunization Practices’ recommendations for respiratory ...

The number of cases of a potentially fatal respiratory infection decreased by about 65 per cent last year following the introduction of a newborn vaccination programme. Respiratory syncytial virus ...

The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca's BEYFORTUS (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and ...

For infants born from October to February, maternal vaccination was cost-effective, but compared with vaccination, nirsevimab ...